Biocomposites acquires remaining shares of SYNICEM and Subiton manufacturers

Biocomposites acquired the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L., gaining full control of the SYNICEM and Subiton antibiotic bone cement product ranges.

“Biocomposites is pleased to announce the acquisition of the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L. – gaining full control of the SYNICEM TM and Subiton product ranges.”biocomposites.com

• 1 source
• biocomposites.comSYNICEM™ & Subiton Products Shares Acquired by BiocompositesSep 18, 2024

Summarized from public sources; check the original articles before acting on it.